Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729504 · ClinicalTrials.gov registry record · NA
Cultural Adaptation of a SSI for Youth Anxiety
A NA study of Anxiety Disorders, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT04729504: Recruiting NA study of Anxiety Disorders, sponsored by University of Miami.
NCT04729504 is a NA study of Anxiety Disorders that is actively recruiting participants, run by University of Miami. The registered enrollment target is 2,000 participants, above the 1,116-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04729504, a NA study of Anxiety Disorders, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.
Primary Outcome
Generalized Anxiety Disorder 2-item (GAD-2) Scale has a total score ranging from 0 to 6 with a score of 3 being the cut-off for identifying possible cases and in which further diagnostic evaluation for generalized anxiety disorder is warranted.
Conditions Studied
Interventions
- BEHAVIORAL Adapted Project BRAVE
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2026-12-21 |
| Phase | NA |
What NCT04729504 shows while recruiting
NCT04729504 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,116-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% higher).
The record links to 1 condition, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Adapted Project BRAVE is the first listed.
NCT04729504 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04729504 about?
NCT04729504 is a clinical study titled "Cultural Adaptation of a SSI for Youth Anxiety". The overarching objective of this protocol is to (1) adapt and (2) disseminate an evidence-based, brief (approximately 30 minute) single session intervention (SSI) to better reflect the cultural and linguistic diversity of Latin, Haitian, and Haitian-American individuals via a fully online platform.
What is the current status of trial NCT04729504?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2021-03-08. Estimated completion is 2026-12-21.
What conditions does trial NCT04729504 study?
This clinical trial studies the following conditions: Anxiety Disorders.
What interventions are being tested in trial NCT04729504?
The interventions under investigation include: Adapted Project BRAVE (BEHAVIORAL).
Who is sponsoring clinical trial NCT04729504?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04729504 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04729504's enrollment target sits among peer trials
2,000 7th of 84 higher than 78 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI